Celebrate Small Wins Every pound lost and every healthy habit gained is a step toward your ultimate goal
Bischoff, H., Pharmacology of alpha-glucosidase inhibition
Over the last few years, several regulatory authorities, such as the FDA and EMA, reported the incidence of mood alterations, depressive symptoms, and even suicidal thoughts with the use of GLP-1 receptor agonists during the pharmacovigilance surveillance process, which raises the issue of their psychiatric safety [13,14,15]
Peer-reviewed articles from reputable sources like PMC have shed light on the peptide's effectiveness in accelerating skin repair and reducing signs of aging
The FDA is currently reviewing a decision from 2023 by Biden administration that restricted compounding certain peptides because there werent enough human safety studies